Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Similar
Filing Names

Amylin Pharmaceuticals Llc
Amylin Pharmaceuticals Llc_20131212
  

Amylin Pharmaceuticals Llc patents

Recent patent applications related to Amylin Pharmaceuticals Llc. Amylin Pharmaceuticals Llc is listed as an Agent/Assignee. Note: Amylin Pharmaceuticals Llc may have other listings under different names/spellings. We're not affiliated with Amylin Pharmaceuticals Llc, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "A" | Amylin Pharmaceuticals Llc-related inventors




Date Amylin Pharmaceuticals Llc patents (updated weekly) - BOOKMARK this page
04/27/17Engineered polypeptides having enhanced duration of action
12/15/16Glp-1 receptor agonist compounds for obstructive sleep apnea
12/01/16Sustained release formulations using non-aqueous carriers
09/22/16Methods for treating diabetes and reducing body weight
05/05/16Pharmaceutical formulations comprising incretin mimetic peptide and aprotic polar solvent
09/17/15Glp-1 receptor agonist compounds for obstructive sleep apnea
08/27/15Exendins to lower cholesterol and triglycerides
08/20/15Pancreatic polypeptide family motifs, polypeptides and methods comprising the same
06/25/15Insulin-pramlintide compositions and methods for making and using them
06/11/15Transmucosal delivery of peptides and proteins
06/04/15Methods for treating diabetes and reducing body weight
06/04/15Methods to restore glycemic control
05/14/15Transmucosal delivery of engineered polypeptides
04/23/15Site-specific enzymatic modification of exendins and analogs thereof
04/23/15Pharmaceutical formulations comprising incretin mimetic peptide and aprotic polar solvent
03/19/15Exendins and exendin agonist analogs to regulate gastrointestinal motility
03/19/15Formulations and uses of exendins and exendin agonist analogs
02/26/15Sustained release formulations using non-aqueous carriers
12/18/14Peptide-peptidase inhibitor conjugates and methods of using same
09/11/14Engineered poypeptides having enhanced duration of action and reduced immunogenicity
09/04/14Amylin-calcitonin chimeric peptides conjugated to duration enhancing moieties
09/04/14Gel compositions
09/04/14Hybrid polypeptides with selectable properties
08/21/14Engineered polypeptides having enhanced duration of action with reduced immunogenicity
08/07/14Method for treating diabetes with extended release formulation of glp-1 receptor agonists
08/07/14Long duration dual hormone conjugates
08/07/14Amylin peptides and derivatives and uses thereof
07/17/14Treatment of cardiac arrhythmias
06/12/14N-terminus conformationally constrained glp-1 receptor agonist compounds
05/15/14Peptide yy and peptide yy agonists for treatment of metabolic disorders
04/17/14Engineered polypeptides having enhanced duration of action
03/06/14Methods for affecting body composition
03/06/14Polypeptide conjugate
02/27/14Glp-1 receptor agonist compounds for obstructive sleep apnea
02/06/14Modified exendins and exendin agonists
12/12/13Exendins and exendin agonist analogs to regulate gastrointestinal motility
11/07/13Microcrystalline y receptor agonists
08/29/13Compositions and methods for the control, prevention and treatment of obesity and eating disorders
08/15/13Prevention and treatment of cardiac arrhythmias
08/08/13Highly soluble leptins
08/01/13Gip analog and hybrid polypeptides with selectable properties
07/18/13Glp-1 receptor agonist compounds having stabilized regions
07/18/13Amylin and amylin agonists for treating psychiatric diseases and disorders
07/04/13Methods for treating diabetes and reducing body weight
07/04/13Exendins to lower cholesterol and triglycerides
06/27/13Formulations of exendins and exendin agonist analogs
05/30/13Gip analog and hybrid polypeptides with selectable properties
04/11/13Glp-1 receptor agonist bioassay
02/07/13Neuromedin and fn-38 peptides for psychotic diseases
01/24/13Peptide yy and peptide yy agonists for treatment of metabolic disorders
01/24/13Exendin and exendin agonists for eating disorders
12/12/13Exendins and exendin agonist analogs to regulate gastrointestinal motility







ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Amylin Pharmaceuticals Llc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Amylin Pharmaceuticals Llc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';